BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34511597)

  • 1. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis.
    Zhang B; Chen X; Ru F; Gan Y; Li B; Xia W; Dai G; He Y; Chen Z
    Cell Death Dis; 2021 Sep; 12(9):843. PubMed ID: 34511597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
    Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
    Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferitrin attenuates unilateral ureteral obstruction-induced renal inflammation and fibrosis in mice by inhibiting NOX4-mediated tubular ferroptosis.
    Li J; Yang J; Xian Q; Su H; Ni Y; Wang L
    Phytother Res; 2024 Jun; 38(6):2656-2668. PubMed ID: 38487990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tectorigenin protects against unilateral ureteral obstruction by inhibiting Smad3-mediated ferroptosis and fibrosis.
    Li J; Yang J; Zhu B; Fan J; Hu Q; Wang L
    Phytother Res; 2022 Jan; 36(1):475-487. PubMed ID: 34964161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling.
    Zhu B; Ni Y; Gong Y; Kang X; Guo H; Liu X; Li J; Wang L
    Life Sci; 2023 Feb; 315():121331. PubMed ID: 36586573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirudin improves renal interstitial fibrosis by reducing renal tubule injury and inflammation in unilateral ureteral obstruction (UUO) mice.
    Xie Y; Lan F; Zhao J; Shi W
    Int Immunopharmacol; 2020 Apr; 81():106249. PubMed ID: 32066115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.
    Zhang X; Lu H; Xie S; Wu C; Guo Y; Xiao Y; Zheng S; Zhu H; Zhang Y; Bai Y
    Br J Pharmacol; 2019 Dec; 176(24):4745-4759. PubMed ID: 31454852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease.
    Dai Y; Chen Y; Mo D; Jin R; Huang Y; Zhang L; Zhang C; Gao H; Yan Q
    Commun Biol; 2023 Sep; 6(1):907. PubMed ID: 37670055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liproxstatin-1 Attenuates Morphine Tolerance through Inhibiting Spinal Ferroptosis-like Cell Death.
    Chen X; Zhang B; Liu T; Feng M; Zhang Y; Zhang C; Yao W; Wan L
    ACS Chem Neurosci; 2019 Dec; 10(12):4824-4833. PubMed ID: 31682397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
    Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
    Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels.
    Feng Y; Madungwe NB; Imam Aliagan AD; Tombo N; Bopassa JC
    Biochem Biophys Res Commun; 2019 Dec; 520(3):606-611. PubMed ID: 31623831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early differential expression of oncostatin M in obstructive nephropathy.
    Elbjeirami WM; Truong LD; Tawil A; Wang W; Dawson S; Lan HY; Zhang P; Garcia GE; Wayne Smith C
    J Interferon Cytokine Res; 2010 Jul; 30(7):513-23. PubMed ID: 20626292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
    Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
    Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.
    Sakai N; Chun J; Duffield JS; Lagares D; Wada T; Luster AD; Tager AM
    Kidney Int; 2017 Mar; 91(3):628-641. PubMed ID: 27927603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
    Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
    Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorafenib Inhibits Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Macrophage Infiltration.
    Ma W; Tao L; Wang X; Liu Q; Zhang W; Li Q; He C; Xue D; Zhang J; Liu C
    Cell Physiol Biochem; 2016; 39(5):1837-1849. PubMed ID: 27744426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
    Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
    Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of HER2 in tubular epithelial cell drives fibroblast activation and renal fibrosis.
    Li H; Shao F; Qian B; Sun Y; Huang Z; Ding Z; Dong L; Chen J; Zhang J; Zang Y
    Kidney Int; 2019 Sep; 96(3):674-688. PubMed ID: 31327474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.